Alvotech
Business
Alvotech is a vertically integrated biotechnology company developing and manufacturing biosimilar medicines. The company markets five approved biosimilars across the United States, Canada, European Economic Area, United Kingdom, and Japan through commercial partnerships where partners handle marketing while Alvotech manufactures and supplies products. The company maintains R&D and cGMP manufacturing facilities in Iceland, Sweden, Switzerland, Germany, and India, with a pipeline of 30 additional product candidates in development.
Summary from 20-F filed 2026-03-31
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $27.90M |
| Total assets | $1.49B |
| Total liabilities | $1.77B |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Alvotech's CIK number?
Alvotech's SEC CIK number is 0001898416 (1898416). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Alvotech's SEC filings?
All of Alvotech's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.